NCT00032916Unknown1 期
Drug Interaction Study With NS2359 and Cocaine in Cocaine Experienced Volunteers
适应症
相关药物
试验速览
- 阶段
- 1 期
- 入组人数
- 24
- 试验地点
- 2
- 主要终点
- Pharmacokinetic parameter comparison
研究概览
简要总结
The purpose of this study is to conduct a drug interaction study with NS2359 and cocaine in cocaine experienced volunteers.
详细描述
This is a single-center, double-blind, placebo-controlled, randomized, single dose, fixed order, dose escalating inpatient design that will study oral NS2359 in cocaine experienced volunteers.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or Female, 18-45 yrs of age; females of child-bearing potential using appropriate method of birth control; be able to understand the procedure and agrees to participate via informed consent; must be cocaine dependent according to DSM-4 criteria; must be capable of providing written consent; must be able to comply with protocol requirement, CPU rules and regulations; must not be currently seeking treatment for cocaine abuse.
排除标准
- •Incapable of understanding the informed consent process; Additional criteria available during screening at the site.
结局指标
主要结局
Pharmacokinetic parameter comparison
plasma concentration
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
Pharmacological Modulation of Cocaine Effects - 1Cocaine-Related DisordersNCT00000201National Institute on Drug Abuse (NIDA)
Unknown
1 期
Assessment of Potential Interactions Between GBR 12909 and Cocaine - 1Cocaine-Related DisordersNCT00100113National Institute on Drug Abuse (NIDA)24
Unknown
1 期
Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1Cocaine-Related DisordersNCT00051896National Institute on Drug Abuse (NIDA)24
已完成
2 期
Trial Of NS2359 For The Treatment of Cocaine DependenceCocaine Use DisorderNCT02798627University of Pennsylvania55
已完成
1 期
Cocaine-Methylphendidate Interaction Study - 4Cocaine-Related DisordersNCT00015067National Institute on Drug Abuse (NIDA)8